Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Roche (Genentech) - Actemra®(tocilizumab)
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential - Ghasemi - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
WHO prequalifies Roche's tocilizumab as its first monoclonal antibody treatment for COVID-19 - Homeland Preparedness News
Coronavirus : l'Actemra de Roche marque un point contre le Covid 19 | Les Echos
Roche's arthritis drug lowers deaths in hospitalised Covid-19 patients
Actemra; coronavirus complications to be treated under Chinese approval
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
FDA Advisory No.2021-2407 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product “Tocilizumab Injection Actemra® 400 mg/ 20 mL” - Food and Drug Administration
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
FDA approves Roche's Actemra COVID-19 trial - PMLiVE
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – Spicyip
Health System News Teamwork Tackles Tocilizumab
Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests | CBC News
:quality(90)/ "Roche | Actemra")
Roche | Actemra
Roche won't contest Hetero Drug's tocilizumab copy | Mint
Roche | Actemra/RoActemra (tocilizumab)
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
FDA approves Roche's Actemra for COVID-19
Roche's Actemra fails to meet Phase III goals in Covid-19 patients
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
Drug vignettes: Tocilizumab - The Centre for Evidence-Based Medicine
Tocilizumab Actemra 400mg by cipla Roche at Rs 39000/vial | Tocilizumab Injection in Ahmedabad | ID: 25556328448
Tocilizumab May Benefit Certain Severe COVID-19 Patients | MedPage Today
Roche warns of shortage of Covid-19 drug tocilizumab - The Hindu BusinessLine
